Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Deciphera Pharmaceuticals Inc. (DCPH)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Redmile Group

Jeremy Green

5,116,263 $210,637 +9% 5.9%
2.
Eversept Partners

Kamran Moghtaderi

414,081 $17,048 +222% 4.31%
3.
VenBio Select Advisor

Kurt Von Emster

2,000,000 $82,340 +300% 2.77%
4.
Opaleye Management

James A. Silverman

222,000 $9,140 -2% 2.42%
5.
Sectoral Asset Management

Jerome Pfund And Michael Sjostrom

204,059 $8,401 1.61%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$17.00 375,000 Large Shareholder 2,146,308 2017-10-02 Filing
$17.00 375,000 Large Shareholder, Director 2,146,308 2017-10-02 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$55.56 2,605 Officer 7,040 2020-05-11 Filing
$55.08 9,395 Officer 9,645 2020-05-11 Filing
$58.00 8,000 Director 0 2020-04-28 Filing
$56.96 3,981 Director 8,000 2020-04-28 Filing
$56.31 11,819 Director 11,981 2020-04-28 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 2,086,723 $85,910 25.69%
2. 449,951 $18,525 15.53%
3. 96,299 $3,965 3.98%
4. 800,000 $32,936 1.39%
5. 1,684,594 $69,355 0.91%